Founded in 2017, CloudCath is a digital health medical device company that is dedicated to remote complication monitoring for patients undergoing catheter-based treatments. Its remote monitoring platform analyzes drainage fluid, utilizing proprietary data analysis algorithms to detect fluid property deviations, and automatically transmits notifications to healthcare providers, enabling earlier intervention in cases of catheter-associated complications like infection. CloudCath's first product is designed for patients undergoing peritoneal dialysis.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/13/20 | $12,000,000 | Series A |
Capital Integral Coconut Tree Investments Stanford-StartX Fund The Capital Partnership | undisclosed |
